EP2438940A1 — Auto injector with a torsion spring
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-04-11 · 14y expired
What this patent protects
The invention relates to an auto-injector (1) for administering a dose of a liquid medicament (M), comprising: - an elongate housing (2) arranged to contain a syringe (7), wherein the syringe (7) is slidably arranged with respect to the housing (2), - spring means (14) capable …
USPTO Abstract
The invention relates to an auto-injector (1) for administering a dose of a liquid medicament (M), comprising: - an elongate housing (2) arranged to contain a syringe (7), wherein the syringe (7) is slidably arranged with respect to the housing (2), - spring means (14) capable of, upon activation, pushing the needle (9) from a covered position inside the housing (2) into an advanced position through the orifice and past the proximal end (P) as well as operating the syringe (7) to supply the dose of medicament (M), - activating means (4) arranged to lock the spring means (14). The spring means (14) is a torsion spring (14). The activating means (4) is a trigger button (4), arranged at a distal end (D) of the housing (2) and operable by being pressed in proximal direction (P).
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.